ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1335

Sarcopenia Is Associated With Joint Damage In Rheumatoid Arthritis patients a Cross Sectional Study In a Peruvian Population

Erika Noriega1, Rocio V. Gamboa-Cardenas1, Manuel F. Ugarte-Gil2,3, Mariela Medina-Chinchon2, Francisco Zevallos-Miranda2, J. Mariano Cucho-Venegas2, Risto A. Perich-Campos2,4, Jose L. Alfaro-Lozano2, Zoila Rodriguez-Bellido2,4 and Cesar A. Pastor-Asurza2,4, 1Rheumatology, Hospital Almenara, Lima, Peru, 2Rheumatology, Hospital Guillermo Almenara, EsSalud, Lima, Peru, 3Universidad Cientifica del Sur, Lima, Peru, 4Universidad Nacional Mayor de San Marcos, Lima, Peru

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects II: Predictors of Disease Course in Rheumatoid Arthritis - Treatment Approaches

Session Type: Abstract Submissions (ACR)

Background/Purpose: Sarcopenia is a low-level, smoldering inflammatory state driven by cytokines and oxidative stress. In rheumatoid arthritis (RA) the relationship between sarcopenia and severity of disease as reflected by joint damage (JD) has not been established. The aim of this study was to determine the association between sarcopenia and joint damage in patients with RA.

Methods: We conducted a single center cross-sectional study. All subjects were older than 18 years at diagnosis and met the ACR criteria. We excluded patients with prosthetic or metallic elements, infections, trauma/ recent surgery, cancer, hospitalized, neurological sequelae from stroke, pregnant or weight> 140 kg. Appendicular skeletal muscle mass (ASM) was measured using dual X-ray absorptiometry (DXA), sarcopenia was define as ASM⁄m2 less than 5.45 kg⁄m2, we assessed physical performance using the Short Physical Performance Battery  (SPPB) and muscle strength of the knee and elbow flexion⁄extension using a digital  dynamometer. A blinded investigator to sarcopenia status determined JD score according to Sharp van der Heidje method. An univariated linear regression model to determine association between sarcopenia and joint damage was applied after that, a multiple regression model, ajusted to age, disease duration, diagnosis delay, DAS28CRP, Fn-HAQ and current doses of  prednisone, was performed to determine persistence of the association. Data was analyzed using SPSS v20.0 .

Results: Ninety three women were evaluated, mean (SD) age was 51.56 (10.21) years, disease duration was 14.12 (8.86), and diagnostic delay was 1.73 (2.28) years, 83% were rheumatoid factor positive.  Fn-HAQ score was 3.15 (1.50) and DAS28-CRP: 3.52 (1.06). The average value of ASM was 13.48 (2.63) kg⁄m2. Twenty seven (29%) patients were found to be sarcopenic. Patients with sarcopenia had lower muscle strength and performance. In the multivariate linear regression model sarcopenia was independently associated with JD (β: 0.261, p: 0.031).

Conclusion: Sarcopenia was associated with JD in our female patients with RA independently of other well­ known risk factors for damage. Sarcopenia contributes to physical frailty, an state that distinct from functional disability, contributes indeed to adverse patient outcomes.


Disclosure:

E. Noriega,
None;

R. V. Gamboa-Cardenas,
None;

M. F. Ugarte-Gil,
None;

M. Medina-Chinchon,
None;

F. Zevallos-Miranda,
None;

J. M. Cucho-Venegas,
None;

R. A. Perich-Campos,
None;

J. L. Alfaro-Lozano,
None;

Z. Rodriguez-Bellido,
None;

C. A. Pastor-Asurza,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sarcopenia-is-associated-with-joint-damage-in-rheumatoid-arthritis-patients-a-cross-sectional-study-in-a-peruvian-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology